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Abstract
Objective—This study estimates additional average health care expenditures for overweight and 
obesity for adults with disabilities vs. without.
Design and Methods—Descriptive and multivariate methods were used to estimate additional 
health expenditures by service type, age group, and payer using 2004–2007 Medical Expenditure 
Panel Survey data.
Results—In 2007, 37% of community-dwelling Americans with disabilities were obese vs. 27% 
of the total population. People with disabilities had almost three times ($2,459) the additional 
average obesity cost of people without disabilities ($889). Prescription drug expenditures for 
obese people with disabilities were three times as high and outpatient expenditures were 74% 
higher. People with disabilities in the 45- to 64-year age group had the highest obesity 
expenditures. Medicare had the highest additional average obesity expenditures among payers. 
Among people with prescription drug expenditures, obese people with disabilities had nine times 
the prevalence of diabetes as normal weight people with disabilities. Overweight people with and 
without disabilities had lower expenditures than normal-weight people with and without 
disabilities.
Conclusions—Obesity results in substantial additional health care expenditures for people with 
disabilities. These additional expenditures pose a serious current and future problem, given the 
potential for higher obesity prevalence in the coming decade.
Introduction
Obesity is a major public health problem and a risk factor for other medical conditions, 
including hypertension, dyslipidemia, cardiovascular disease, diabetes, and arthritis (1–9). It 
is also associated with increased disability (10–13) and, at the highest weight levels, 
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mortality (14–17). Health care expenditures attributable to obesity were ~10% of total health 
care spending in 2006 (18).
Obesity, typically defined as having a body mass index (BMI) of 30 or greater, has become 
more prevalent among adults in the US in recent years according to National Health and 
Nutrition Examination Survey (NHANES) data. Age-adjusted obesity among men age 20 
and greater increased 17.1% between 1999 and 2008. Among women age 20 and over 
during the same period, the increase was 6.3% (19). However, recent research suggests that 
the growth rate in obesity for some population groups is slowing (20).
People with disabilities are an important segment of the population with excess weight 
(overweight or obese). Approximately 18.7% of the civilian noninstitutionalized US 
population in 2010 had a disability lasting any length of time (21). People with disabilities 
also have high health care expenditures (22,23). Disability-associated health care 
expenditures totaled $397.8 billion in 2006, with disability status adding an average of 
$11,637 additional health care expenditures (24).
To date, researchers, clinicians, and public health policy makers have considered obesity 
generally without focusing on people with disabilities who have excess weight. Obesity is a 
leading secondary condition reported by people with disabilities (25). Obesity expenditures 
may be higher for people with disabilities compared to those without disabilities for several 
reasons. People with disabilities may be heavier than those without disabilities, which may 
make them sicker. Thus, people with disabilities who are obese may require additional 
monitoring or medical care, and may have higher expenditures. In addition, obesity in 
people with disabilities may limit mobility such that they may not get to the doctor for 
regular medical care until their problems become more urgent, and perhaps more expensive.
If health care expenditures are higher among obese people with disabilities compared to 
those without disabilities, additional focus on obese people with disabilities may be 
warranted to address unmet health care needs. In addition, policy makers may want to focus 
on obese people most at risk for disability to prevent even higher health care expenditures 
and loss of health. Understanding these expenditures for important subgroups (e.g., age and 
payer) may also inform choices by policy makers in designing programs and allocating 
resources.
This study compares differences in health care expenditures between people with excess 
weight who have disabilities and people with excess weight without disabilities. It addresses 
the following research questions: (1) What is the prevalence of overweight and obesity 
among noninstitutionalized adults with and without disabilities? (2) What are the relative 
additional health care expenditures for being overweight and obese (compared to normal 
weight) among noninstitutionalized adults with and without disabilities? (3) What types of 
health care services have the highest expenditures associated with obesity for people with 
and without disabilities? (4) Which age and payer (Medicare, Medicaid, private pay) 
subgroups within these two populations have the highest expenditures?
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Data were obtained from two sources. First, a disability measure was developed from the 
2003–2006 National Health Interview Survey (NHIS), a nationally representative survey 
sponsored by the National Center for Health Statistics. Second, measures of health care 
expenditures, weight status, and demographic and socioeconomic information on the civilian 
noninstitutionalized adult population were developed from the 2004–2007 Medical 
Expenditure Panel Survey (MEPS), a nationally representative survey sponsored by the 
Agency for Healthcare Research and Quality (AHRQ) and drawn from a subsample of 
households that participated in the NHIS. The analytic sample of 39,457 adults aged 19 and 
older was taken from the NHIS Sample Adult File.
The study used descriptive and multivariate methods. Means or proportions were estimated 
to compare demographic and socioeconomic characteristics, expenditures, and prevalence of 
conditions for those with excess weight for two different subgroups: those people with and 
without disabilities. Means were also estimated for people by weight category, disability 
status and prevalence of having various medical conditions.
Multivariate methods were used to estimate the additional expenditures of being overweight 
or obese for people with disabilities vs. without. Two types of dependent variables for total 
and service-specific expenditures were developed. The first type was a dummy variable for 
any MEPS health care expenditures (e.g., any expenditures for use in Logit models), and the 
second type was a continuous variable for the amount of expenditures (e.g., amount of total 
expenditures if expenditures greater than zero). Expenditures are presented in 2007 dollars 
and the weights for each person adjusted to obtain 2007 annual health care expenditures. 
The dependent variable for total health care expenditures comprised inpatient, outpatient, 
prescription drug, home health care, emergency room, vision and dental services, and 
durable medical equipment for all payers. Mean total health care expenditures for the entire 
weighted sample in 2007 dollars were $4,841 ($5,510 for the 33,846 sample adults with any 
health expenditures).
The study included several policy variables. Variables for weight status were defined as 
underweight (BMI < 18.5, 3.9% of the sample), normal weight (BMI 18.5–24.99, 34.3% of 
the sample), overweight (BMI 25.0–29.99, 34.2% of the sample), and obese weight (BMI 
≥30, 27.6% of the sample). Using questions in the NHIS, disability was defined as having a 
limitation in any way in any activity because of a physical, mental, or emotional problem. 
The definition included all people reporting a deficit in activities of daily living (ADL), such 
as bathing, eating, or toileting, or instrumental activities of daily living (IADL), such as 
shopping and bill paying. Approximately 15.7% of respondents in the weighted sample 
reported a disability. Independent variables included in the models were self-reported health 
status, demographic characteristics (age, gender, race/ethnicity, and marital status), 
socioeconomic status (education and income), geographic region, and dummy variables for 
MEPS year. Summary statistics for the variables used in the analysis appear in Table 1.
Health care expenditures were estimated with the MEPS sample weights using a two-part 
model using Logit in the first part and a general linear model (GLM) with a gamma 
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distribution and a log link in the second part on positive expenditures. Weight and disability 
status were the principal variables of interest. Health care expenditures were estimated 
separately for people using specific services (inpatient, outpatient, home health, prescription 
drug, and emergency room). These expenditures were also estimated separately for people in 
various age groups, and separately for people with specific payer types, using either total 
expenditures or expenditures for specific service types (e.g., inpatient hospital care). After 
each regression ran, predictions were made for two subgroups—those people with and 
without disabilities—to estimate the additional average expenditures of being overweight 
and obese. A total of 21 regressions were estimated to generate the expenditures and 
bootstrapped standard errors presented in the study. The regression coefficients are available 
from the authors upon request. The methods used are similar to prior studies estimating 
additional health care expenditures for obesity (18) and disability (24).
The additional health care expenditures associated with being obese (compared with being 
of normal weight) were calculated post-estimation in 2007 dollars by predicting the 
dependent variable for the Logit and GLM models and then multiplying the predicted values 
for each respondent. This product is the predicted probability of any expenditures for each 
person times the predicted amount of expenditures for each person from the GLM 
regression. Then, people with obesity were recoded as having no obesity, to remove the 
obesity-related effect on health care expenditures. Predictions for the dependent variable 
were again made for the Logit and GLM models and multiplied. The average of the 
difference between these two products for each person, the first calculated using the whole 
MEPS sample, and the second for the same respondents less any obesity-related 
expenditures, was the amount of health care expenditures associated with obesity in the 
sample. The same predictions of additional health care expenditures for overweight people 
(as compared with people of normal weight) were also obtained. The models used in our 
analyses control for disability status as an independent variable, so the additional overweight 
and obesity cost estimates are independent of disability costs.
Results
Our descriptive analyses found that 69.9 million (34%) of 205 million community-dwelling 
Americans were overweight in 2007, and 56.3 million people (27%) were obese (Figure 1). 
Of the 32 million people with disabilities in these data, 30% were overweight and 37% were 
obese. Comparatively, obesity prevalence was about 1.35 times higher among people with 
disabilities as in the general community-dwelling population. For each weight status level, 
people with disabilities have approximately three times higher mean total health care 
expenditures as people without disabilities (Table 2).
In multivariate analyses estimating total health care expenditures, the additional average cost 
of being obese for people with disabilities ($2,459) was almost three times the additional 
cost of obesity for people without disabilities ($889) (Table 3). Additional average 
expenditures for obese people with disabilities by service type were at least as high as, and 
sometimes considerably higher than, additional average expenditures for obese people 
without disabilities. The service type with the highest additional average obesity 
expenditures was prescription drugs, whose expenditures were three times as high for people 
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with disabilities ($1,297) as for those without disabilities ($414). Additional average obesity 
outpatient and emergency room expenditures were also statistically significantly higher 
(each being 74% higher for people with disabilities than without).
For some types of services overweight people with and without disabilities had statistically 
significantly lower expenditures than persons of normal weight with and without disabilities. 
For example, overweight people with disabilities had lower inpatient expenditures (−$733) 
than normal weight people with disabilities; overweight persons without disabilities also had 
lower inpatient expenditures than normal weight people without disabilities (−$213), but the 
difference was not as great. Across services types, overweight people with disabilities 
usually had much lower expenditures than normal weight people with disabilities. The same 
was true for overweight people without disabilities. The exception was the statistically 
significantly positive additional prescription drug expenditures for overweight people with 
($296) and without ($101) disabilities, as compared with normal weight people with and 
without disabilities.
To help explain the large additional overweight- and obesity-related prescription drug 
expenditures among people with disabilities, the prevalence of having various medical 
conditions in MEPS data was estimated using descriptive statistics (Table 4). Among 
prescription drug users, the top 10 (out of 32) conditions among people with disabilities 
were similar for both overweight and obese people. However, the prevalence of such 
conditions was 25–60% higher among obese than among normal-weight people. Compared 
with normal-weight people with disabilities, overweight people with disabilities had 
approximately a 10, 20, and 30% higher prevalence of arthritis, hypertension, and high 
cholesterol, respectively. These conditions represent the top three conditions for both the 
overweight and obesity subgroups. Among prescription drug users, diabetes was the fourth-
leading condition experienced by obese people with disabilities, even though it was not 
among the top 10 conditions for overweight or normal-weight people with disabilities with 
such expenditures.
We also examined whether obesity expenditures varied by age for people with disabilities 
compared to people without disabilities. Age-group multivariate analyses in Table 5 show 
that additional average obesity expenditures among people with disabilities were highest in 
the 45- to 64-year age group ($2,822), almost 2.5 times the additional average expenditures 
of obese people without disabilities in that age group ($1,197). Moreover, additional average 
obesity expenditures for people with disabilities aged 18 to 44 ($2,442) were triple those of 
people without disabilities ($812). Because MEPS data exclude persons in institutions, 
substantial amounts of obesity expenditures among people with disabilities aged 65 years 
and older were not included in the analyses, and mean excess costs in the analyses might 
have been higher had they been included.
Lastly, we examined whether obesity expenditures varied by payer type for people with 
disabilities compared to those without. Health care expenditures for obese people with 
disabilities were higher, and the difference was statistically significant, for each third-party 
and other payers (Table 6). Compared with normal-weight people with disabilities for each 
respective payer, additional obesity expenditures were highest for people with disabilities 
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who had Medicare coverage ($2,929), followed by those who had private insurance ($2,449) 
and those with Medicaid ($2,397).
Discussion
It is widely recognized that obesity results in substantial additional expenditures for the US 
health care system (18,26). Much less is known about the additional per person obesity 
expenditures for people with disabilities compared to those without. This study found that in 
the 2004–2007 civilian, community-dwelling adult population, average additional 
expenditures for obesity among people with disabilities were $2,459, compared with an 
average additional $889 for obese people without disabilities (2007 dollars). Prescription 
drugs, followed by outpatient service expenditures, were the largest drivers of higher 
additional obesity expenditures among people with disabilities. Other studies have also 
found high prescription drug expenditures among obese people in the general population 
(18,26).
Incremental expenditures associated with obesity by disability status vary by age. Our 
findings revealed that nonelderly obese persons with disabilities had almost triple the 
obesity expenditures of nonelderly obese persons without disabilities. In particular, the 45- 
to 64-year age group had the highest additional average obesity expenditures. 
Noninstitutionalized elderly persons with and without disabilities had far lower obesity 
expenditures than younger age groups, which is consistent with previous findings (27).
A substantial portion of people with disabilities are obese. People with disabilities are at 
higher risk of obesity because some conditions such as arthritis and diabetes are 
characterized by high levels of functional impairment. Arthritis can readily limit mobility, 
which may result in substantial weight gain over time. For diabetes, weight gain can be a 
byproduct of insulin use if patients do not effectively manage their weight (28). The 
coexistence of disability, obesity, and serious chronic conditions may result in very high 
health care expenditures.
Conversely, as shown in Figure 1, over one-fifth of obese people have a disability. Obese 
people may be at a higher risk of disability because of their higher prevalence of chronic 
conditions, such as cardiovascular disease and dyslipidemia, which may result in disability-
producing events such as heart attack and stroke (1,2,4). Obesity may also result in 
depression (29), injury (30), and back disorders (31), all of which may produce lengthy 
periods of disability.
The additional obesity expenditures are so much higher for people with disabilities 
compared to those without disabilities highlights the need to focus on preventing, reducing, 
or better controlling secondary conditions for obese people with disabilities. The 
multivariate analyses in this study controlled for the effects of disability, so the higher 
additional obesity expenditures for people with disability compared with those without are 
for conditions secondary to their disability. Given the higher prevalence of arthritis, high 
cholesterol, hypertension, and diabetes among obese people with disabilities as compared 
with normal-weight people with disabilities, and that disability per se does not cause these 
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conditions, care management initiatives to lower the prevalence or reduce the effects of 
these secondary conditions may reduce ensuing disability or its effects. Health promotion 
and disease-prevention initiatives may also help reduce secondary conditions among people 
with disabilities (32–34). Such a focus may also help to reduce the substantially higher 
outpatient service expenditures related to these conditions experienced by obese people with 
disabilities.
In addition, given that people with disabilities have poorer health and high health care 
expenditures, identifying obese persons most at risk for disability offers the potential to have 
a high impact on the health of obese persons and on health care expenditures. Identifying 
such people should be the focus of future research. Targeted health promotion and disease-
prevention initiatives that consider special needs of obese people with disabilities alsomay 
be beneficial to the overall obese population.
Among the nonobese population with disabilities, additional clinic-level interventions 
focusing on prevention are needed. People with disabilities at normal weight may benefit 
from counseling regarding physical activity and nutrition. Care coordination efforts should 
focus not only on a person’s disability (35), but also on the prevention and treatment of 
secondary conditions that may lead to obesity (25). In addition, clinicians may require 
further education on the extra burden that obesity places on people with disabilities, both in 
terms of trying to help people lose weight, but also in watching for additional complications 
(35).
Most public health interventions (e.g., exercise) targeting obesity are not designed to meet 
the needs of people with disabilities. Consequently, community-level environmental 
interventions with appropriate outreach should be designed to help people with disabilities 
make healthier lifestyle choices in terms of physical activity and nutrition. For example, 
wheelchair accessible sidewalks, parks and exercise centers to facilitate physical activity and 
funding for initiatives to encourage access to grocery stores, supermarkets, and farmers 
markets may help promote wise food choices. Finally, interventions designed to prevent, 
delay, or reduce obesity for people with disabilities would benefit from the input of people 
with disabilities and specific data on people with disabilities.
This study found lower expenditures for being overweight (BMI of 25 to <30) compared 
with normal weight (regardless of disability status), which may indicate a protective effect 
for being overweight. Prior work on expenditure outcomes with similar methods found no 
difference in additional mean expenditures for normal weight vs. overweight (26), and being 
overweight may improve survival for noncancer, noncardiovascular mortality (36). In 
addition, previous studies in the older population (12,37), particularly those in nursing 
homes (38), have shown a protective effect for higher BMI (being either overweight or 
obese) as opposed to being normal weight in terms of reducing health care expenditures. Our 
study’s finding suggests that overweight people may benefit from interventions to prevent 
them from becoming obese. The “protective effect” for being overweight is larger for people 
with disabilities because their average total expenditures are much higher than people 
without disabilities, so the potential cost savings may be larger.
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This study has at least four limitations. First, we estimated additional average expenditures 
for overweight and obesity using an inclusive definition of disability and estimated 
prevalence. Alternatively, other researchers might have chosen a different definition of 
disability, for example, one with more stringent permanence or severity criteria. How the 
concept of disability is measured depends on the definition chosen and available data. Given 
that we estimated per person additional overweight and obese expenditures for people with 
vs. without disabilities, we believe any differences in effects estimated using a narrower 
definition of disability may have been slightly larger than what we reported in this study.
Second, the regression methodology used did not control for other medical conditions such 
as diabetes. Therefore, the reported estimates for additional average obesity and overweight 
expenditures would have been somewhat lower had these other medical conditions been 
taken into account. Third, the methodology used did not assess the issue of causality—
whether obesity was the cause of disability, and vice versa. Although causality was not 
within the scope of the study, research on causality would be of particular interest to 
practitioners as well as policy makers. Fourth, BMI is just one measure of obesity; other 
measures of obesity may be more or less relevant for people with disabilities, whose 
impairments as well as medicines may predispose them to greater obesity prevalence. In 
addition, obesity measures derived from self-reported weight are subject to underreporting 
of weight (39).
Given that people with disabilities already have higher health care expenditures (40), these 
additional obesity expenditures pose a serious current as well as future public health 
problem, because of the potential for higher obesity prevalence in the coming decade (19). 
With projections of more people with disabilities coupled with more people with obesity 
(27), the intersection of these two trends might suggest a growing burden of additional 
health care expenditures for obese people. Finding effective interventions to prevent greater 
disability among obese people with disabilities, as well as those interventions to prevent 
disability among those who are currently obese, may help slow the growth rate in health care 
expenditures as well as improve health for those at risk.
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TABLE 1
Means of variables used in analysis (n = 39,457)
Characteristic Variable Mean or proportion Std. Dev. Std. Err.
Expenditures Total (2007 dollars) 4,841 11,483 —
Inpatient (if any use) 14,528 21,336 —
Outpatient (if any use) 2,068 5,366 —
Home health (if any use) 6,272 9,393 —
Prescription drug (if any use) 1,651 3,387 —
Emergency room (if any use) 1,054 1,918 —
Disability status Any disability 0.157 0.005
Weight status Obese (BMI ≥30) 0.276 0.004
Overweight (BMI 25.0–29.99) 0.342 0.003
Normal weight (BMI 18.5–24.99) 0.343 0.004
Underweight (BMI <18.5) 0.039 0.001
Age 19–44 years 0.451 0.006
45–64 years 0.347 0.004
65–74 years 0.099 0.003
75–84 years 0.075 0.003
85+ years 0.028 0.001
Gender Female 0.549 0.004




Other race 0.021 0.002
Marital status Married 0.475 0.005
Education Less than high school 0.139 0.004
High school graduate 0.497 0.006
College graduate or some college 0.185 0.005
Graduate degree 0.095 0.004
Other degree 0.084 0.002
Income <100% of federal poverty level 0.117 0.003
100–199% of federal poverty level 0.183 0.004
>200% of federal poverty level 0.700 0.006




MEPS year Year 2004 0.246 0.003
Year 2005 0.251 0.002
Year 2006 0.252 0.002
Year 2007 0.252 0.004
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MEPS, Medical Expenditure Panel Survey. Source: RTI International Analysis of the 2004–2007 Medical Expenditure Panel Survey.
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TABLE 2
Mean expenditures by disability and weight status (n = 39,457)
People with disabilities People without disabilities
Normal weight 10,863 3,459
Overweight 9,907 3,375
Obese 11,460 4,132
Source: RTI International Analysis of the 2004–2007 Medical Expenditure Panel Survey.
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